NSP Misled Parents27 January 2004
by Anai Rhoads
The Food and Drug Administration (FDA) announced Friday that the Internet sale of a dietary supplement for infants was found misleading. The product, Better than Formula Ultra Infant Immune Booster 117, was promoted and sold as an additional supplement to infant formula. The product turned out to be regular infant formula and not what the company had claimed. The makers of this product, NSP Research Nutrition of Mt. Clemens, Michigan, has yet to submit a notification that is required under Section 412 of the Federal Food, Drug, and Cosmetic Act which allows the product to be used as an infant formula. This furthers the charges against NSP for failing to label the formula properly for consumers. NSP also failed to register the company's formula with the FDA in the ninety day period prior to martketing and distribution for intent of public sale. Better than Formula Ultra Infant Immune Booster 117's label also listed ingredients not yet evaluated or approved by the FDA. According to the FDA, there are no assurances that have been provided to the agency by the manufacturer that this product as represented for use:
The instructions to mix the product state, "As with adults, infants should have small feedings every 2 to 3 hours throughout the day and should never be overfed." This statement also confirms the company's intent to use the product for use as a meal and not as a dietary supplement. There have been no cases reported of injuries or illnesses directly associated with this product, however the FDA asks parents to speak with their doctor regarding this recall if there are any problems or concerns. ©2004 Veriana Media. Reproduction must be authorised in writing only, and altering the material and this copyright notice is prohibited and protected by international law. Please contact Veriana Media for reprint and licencing permission.
|